Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy
Journal of Surgical Oncology · 2023
DOI: 10.1002/jso.27220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2023. Verfasst von Paul H Sugarbaker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Appendiceal Neoplasms, Peritoneal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous, Adenocarcinoma, Mucinous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Foundation for Applied Research in Gastrointestinal Oncology.
Abstract (Originalsprache)
Background
Incomplete cytoreduction for mucinous appendiceal neoplasms is often required to temporarily alleviate symptoms. The surgical technology for this intervention may be complex and result in extensive morbidity and even mortality. Knowledgeable patient selection for this surgery is mandatory.
Methods
A database was used to identify patients who had palliative surgery that included total abdominal colectomy (TAC). Clinical‐ and treatment‐related variables were assessed for their impact on overall survival.
Results
Seventy‐eight patients had an incomplete cytoreductive surgery (CRS) that included a TAC. The median survival was 2.5 years and the median follow‐up was 2 years. Patients with symptoms of abdominal distention and ascites showed a reduced prognosis ( p = 0.0254). The low‐grade appendiceal mucinous neoplasms (LAMN) and mucinous appendiceal adenocarcinoma intermediate type (MACA‐Int) grouped together showed a prolonged survival ( p = 0.0003). MACA with positive lymph nodes showed a reduced survival ( p = 0.0009) when compared to MACA patients without positive lymph nodes. A peritoneal cancer index of 1–30 versus >30 and completeness of cytoreduction score of 2 versus 3 were not significant.
Conclusion
TAC with end ileostomy was used as a treatment option to provide palliation of patients having an incomplete CRS for appendiceal mucinous neoplasms. With LAMN or MACA‐Int, median survival was 5.0 years. The surgery can be performed with a morbidity of 9.0% and mortality of 2.6%. Although not considered a palliative option in the past, these data suggest TAC may be used with acceptable results in this group of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
- Westat, Rockville, Maryland, USA.
Förderung
- Foundation for Applied Research in Gastrointestinal Oncology
Zitieren
APA
Sugarbaker, P. H., & Chang, D. (2023). Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27220
Vancouver
Sugarbaker PH, Chang D. Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy. Journal of Surgical Oncology. 2023. doi:10.1002/jso.27220
BibTeX
@article{Sugarbaker2023,
author = {Sugarbaker, Paul H and Chang, David},
title = {Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy},
journal = {Journal of Surgical Oncology},
year = {2023},
doi = {10.1002/jso.27220}
}
EUVIMED